Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial

Overview of attention for article published in Nature Medicine, March 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog
twitter: 28 X users

facebook: 1 Facebook page
reddit: 1 Redditor
bluesky: 4 Bluesky users

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 29 X posts from 28 X users, with an upper bound of 741,660 followers.

RT @UPENN_ITMAT: Early nonresponse to behavioral obesity treatment doesn’t have to mean failure. Adding anti-obesity medication doubles wei…

原著 Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial. Nature medicine, 10.1038/s41591-025-03556-3. https://t.co/bW8ohcikwU

Beneficios del uso temprano de análogos de GLP-1 en el tratamiento de la obesidad ☝🏽Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial | Nature Medicine https://t.co/3416VW5Y6A

RT @NatureMedicine: A randomized clinical trial shows the superiority of behavioral treatment plus phentermine to behavioral treatment plus…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 25 additional X posts.